» Articles » PMID: 39338032

What Women with HIV Know About Heart Health and Cardiovascular Risk and Intervention Preferences

Abstract

Cardiovascular disease (CVD) is a significant health concern influenced by various determinants. Stigma and resilience have emerged as factors in CVD development and management. Women with HIV (WWH) have higher CVD rates than women without HIV. To improve cardiovascular health for WWH, a comprehensive understanding of how these factors interact, the understanding about individual awareness and willingness to engage in risk-reduction interventions are needed. As part of a study examining CVD risk among WWH aged >35 years old, 90-min focus groups were conducted (May 2022) in the English language. Focus groups aimed to elicit participants' CVD risk knowledge and potential prevention strategies. Transcripts underwent a qualitative analysis. Nineteen WWH participated in three focus groups. Participants experienced the following: (a) enacted stigma related to their HIV diagnosis (e.g., family, church member, healthcare staff); (b) a recent event (e.g., hospitalization of self/family, death in family, chest pain) triggered both heart health-promoting lifestyle changes and suboptimal health behaviors (e.g., COVID-19 pandemic: unhealthy snacking). Participants wanted to obtain more knowledge ("on a mission") about CVD risk. In total, 100% expressed willingness to take medication or embark on other lifestyle changes to prevent future CVD events. Although participants identified preventative heart health behaviors (e.g., eating healthy foods; exercising; limiting stress, substances, and smoking), misconceptions were also identified (e.g., "catching" heart disease). Understanding the interplay of the different factors related to heart health is needed both at the provider and the patient level to inform interventions that reduce CVD risk amongst racial/ethnic minoritized women with HIV, living in the Southern region of the US.

References
1.
Gonah L, Moodley I, Hlongwana K . Prevalence of diabetes mellitus and hypertension in people living with human immunodeficiency virus on antiretroviral therapy in Gweru district, Zimbabwe. Afr J Prim Health Care Fam Med. 2020; 12(1):e1-e6. PMC: 7479366. DOI: 10.4102/phcfm.v12i1.2473. View

2.
Duthely L, Sanchez-Covarrubias A, Brown M, Thomas T, Montgomerie E, Dale S . Pills, PrEP, and Pals: Adherence, Stigma, Resilience, Faith and the Need to Connect Among Minority Women With HIV/AIDS in a US HIV Epicenter. Front Public Health. 2021; 9:667331. PMC: 8255796. DOI: 10.3389/fpubh.2021.667331. View

3.
Mendicino C, Costa A, Silva G, Braga L, Rocha G, Carmo R . Metabolic comorbidities and systemic arterial hypertension: the challenge faced by HIV patients on long-term use of antiretroviral therapy. Hosp Pract (1995). 2022; 50(1):75-81. DOI: 10.1080/21548331.2022.2030564. View

4.
Cioe P, Crawford S, Stein M . Cardiovascular risk-factor knowledge and risk perception among HIV-infected adults. J Assoc Nurses AIDS Care. 2013; 25(1):60-9. PMC: 3875835. DOI: 10.1016/j.jana.2013.07.006. View

5.
Murray C, Zamora C, Shitole S, Christa P, Lee U, Bortnick A . Race-Ethnic Differences of ST-Elevation Myocardial Infarction: Findings from a New York Health System Registry. Ethn Dis. 2022; 32(3):193-202. PMC: 9311301. DOI: 10.18865/ed.32.3.193. View